BMRN vs IRM · P/E 40, rev $1.76B vs P/E 136, rev $3.97B
Biomarin Pharmaceutical Inc (BMRN) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the BMRN and IRM stock pages for the full models.
Not investment advice.